SARS-CoV-2 Mu variant
SARS-CoV-2 Mu variant
The SARS-CoV-2 Mu variant, also known as B.1.621, is a variant of the SARS-CoV-2 virus, which is responsible for the COVID-19 pandemic. The Mu variant was first identified in Colombia in January 2021.
Pronunciation
The term "Mu" is pronounced as /mjuː/, similar to the English word "mew". The term "SARS-CoV-2" is pronounced as /ˈsɑːrz koʊ viː ˈtuː/.
Etymology
The variant is named after the 12th letter of the Greek alphabet, "Mu". The naming follows the World Health Organization's (WHO) decision to name variants of SARS-CoV-2 after letters of the Greek alphabet to avoid stigmatization associated with naming the variants after the locations where they were first identified.
Characteristics
The Mu variant has a number of mutations that potentially allow it to evade the immune response, although further research is needed to confirm this. The WHO has designated it as a variant of interest (VOI).
Related terms
- Variant of Interest (VOI): A variant with specific genetic markers that have been associated with changes to receptor binding, reduced neutralization by antibodies, reduced efficacy of treatments, potential diagnostic impact, or predicted increase in transmissibility or disease severity.
- SARS-CoV-2 Delta variant: Another variant of the SARS-CoV-2 virus, which was first identified in India and has since become dominant in many countries.
- COVID-19 pandemic: The ongoing global pandemic caused by the SARS-CoV-2 virus.
- World Health Organization (WHO): The global health body of the United Nations, which is responsible for international public health.
External links
- Medical encyclopedia article on SARS-CoV-2 Mu variant
- Wikipedia's article - SARS-CoV-2 Mu variant
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski